Oncobit

Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.

Total raised

€4.2M

€4,177,476

Funding rounds

Investors

distinct backers

Active since

2021-04

latest 2025-12

Funding by year

EUR raised per year

High confidence

Raise-next likelihood33

base rate 30% for Other

Exit likelihood12

base rate 12% (2+ rounds)

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2025-12-04	Other	€2.0M	Existing investors,new investors	View deal →
2021-04-30	Seed	€2.1M	AVANTECA Partners,GF Group Holding	View deal →

same sector or country